Clinical Trials in Baltimore

Showing 22041-22060 of 23,476 trials

Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5/X4-Tropic Treatment-Experienced HIV-Infected Subjects

NCT00197197

The purpose of this study is to evaluate the safety and efficacy of the CCR5 antagonist GW873140 or placebo in combination with an optimized background regimen in treatment-experienced HIV-infected subjects with R5/X4-tropic virus

HIV Infection

GlaxoSmithKline18 participantsStarted Jul 2005

Los Angeles, California, United States • Norwalk, Connecticut, United States • Fort Lauderdale, Florida, United States +9 more locations

TERMINATEDPhase 3< 1 mile

Screening Protocol To Determine Eligibility For Studies Of The Chemokine Coreceptor 5 (CCR5) Antagonist GW873140

NCT00123890

The purpose of this study is to determine eligibility for one of three treatment studies of the CCR5 antagonist GW873140 or an observational study without GW873140. No investigational treatment will be administered through this study.

HIV Infection

GlaxoSmithKlineStarted Jun 2005

Tucson, Arizona, United States • Laguna Beach, California, United States • Long Beach, California, United States +39 more locations

Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5/X4-Tropic Treatment-Experienced HIV-Infected Subjects

Screening Protocol To Determine Eligibility For Studies Of The Chemokine Coreceptor 5 (CCR5) Antagonist GW873140

Find Trials by Condition in Baltimore

Serologic Assays for the Diagnosis of Herpes Simplex Virus Type 2

Protect II, A Prospective, Multicenter Randomized Controlled Trial

Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors

Studying Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers

Effects of Zoledronic Acid and Raloxifene on Bone Turnover Markers in Postmenopausal Women With Low Bone Mineral Density

Intervention Study to Compare the Natriuretic Effects of Enalapril on Low and High Salt Diet

Circulating Tumor Cells (CTCs): A Potential Screening Test for Clinically Undetectable Breast Carcinoma

Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Cancer

VX-853 in Treating Patients With Solid Tumors Who Are Receiving Liposomal Doxorubicin

Epirubicin Plus Irinotecan in Treating Patients With Advanced Cancer

Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer

An Effectiveness And Safety Study Of PD 0299685 For The Treatment Of Symptoms Associated With Interstitial Cystitis

Investigating Efficacy and Safety of Two Degarelix Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Ablation Therapy

PROTECT I, A Prospective Feasibility Trial Investigating the Use of IMPELLA RECOVER LP 2.5 System in Patients Undergoing High Risk PCI

Effect of High and Low Sodium Diets on Blood Pressure in Hypertensive Patients Treated With Aliskiren

The Clinic Treatment Project